LabVantage Named a Visionary Leader in Life Sciences and Industrial LIMS by Frost & Sullivan
21.9.2026 10:30:00 CEST | Business Wire | Press release
— Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership — — Frost & Sullivan cited LabVantage CORTEX™ (for life sciences) and LIMS deployments spanning food and beverage, oil and gas, forensics, and government laboratories (for other industrial applications) —
LabVantage Solutions, Inc., a leading global provider of laboratory informatics solutions and services, has been named a Visionary Leader in two 2026 Frost Radar™ reports by Frost & Sullivan: Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026 and Frost Radar™: Laboratory Information Management Systems in Industrial Applications, 2026. Announced at LabVantage’s Customer Training and Education Conference (CTEC) Europe 2026 in Paris, the dual recognition marks LabVantage’s fourth consecutive year of Frost Radar leadership.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921487430/en/
The Frost Radar is an independent benchmarking analysis that evaluates companies on a Growth Index and an Innovation Index. The Growth Index measures a company’s growth performance, track record, and ability to execute its growth strategy, while the Innovation Index assesses its ability to develop globally applicable solutions that evolve with changing customer needs. For the 2026 assessments, Frost & Sullivan benchmarked 16 companies in life sciences and screened 50 vendors in industrial applications, plotting the top 10. LabVantage placed as a Visionary Leader in both.
“LabVantage is the first enterprise LIMS vendor to offer a comprehensive agentic AI framework, called LabVantage CORTEX,” said Anantharaman Viswanathan, Research Director, Frost & Sullivan. “By building LabVantage CORTEX separately from the validated LIMS core, the company allows AI capabilities to evolve quickly without disrupting regulated operations. Combined with a broad footprint across industries well beyond life sciences and strong, double-digit growth in the LIMS market, this earns LabVantage a Visionary Leader position in both of our 2026 LIMS Frost Radar assessments.”
In its life sciences evaluation, Frost & Sullivan highlighted LabVantage’s configurable, browser-based platform, which integrates LIMS, electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics. The report noted that LabVantage CORTEX extends the company’s position from traditional LIMS to AI-enabled laboratory intelligence and enables traceable, auditable AI within laboratory workflows. It also recognized more than 40 years of regulatory expertise, growing SaaS adoption, and customer retention above 98%.
The industrial applications report focused on LabVantage’s footprint beyond life sciences, including food and beverage, oil and gas, consumer goods, forensics, and government laboratories. Frost & Sullivan identified this breadth as a key driver of the company’s strong, double-digit growth in the LIMS market. The report also noted LabVantage’s investments in cybersecurity and compliance, as well as its approach to augmentation over full automation or dark laboratories. This reflects LabVantage’s human-in-the-loop model, in which robotics, automation, and agentic AI support the scaling of routine workflows while scientists retain interpretation and critical decisions.
“I value nothing more than independent validation from the clients and the everyday heroes in the lab,” said Mikael Hagstroem, Chief Executive Officer at LabVantage Solutions. “Offering a trusted agentic AI environment for high-stakes, regulated industries is a proud milestone, and I am incredibly grateful to my colleagues for launching LabVantage CORTEX. Built in collaboration with leading global laboratories, CORTEX delivers relevant and impactful agentic AI that gives scientists trusted auditable automation without compromising compliance or data integrity. Celebrating our fourth consecutive year of Frost Radar leadership at CTEC Europe is the perfect way to honor the customer-led innovation that drives us forward.”
The Frost & Sullivan summary reports are available at this link. For more information on LabVantage and LabVantage CORTEX, visit www.labvantage.com or email info@labvantage.com.
About LabVantage Solutions
LabVantage Solutions is a global leader in laboratory informatics, driving digital transformation through LabVantage CORTEX™. This AI, analytics, and automation platform unifies LIMS, ELN, LES, SDMS, and analytics in a 100% browser-based environment with agentic AI. With 40+ years of LIMS expertise and 1,500+ customers across industries, LabVantage helps streamline workflows and support compliance. Headquartered in Somerset, New Jersey, LabVantage serves customers worldwide through global teams, regional offices, and partners. Learn more at www.labvantage.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260921487430/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom